Addition of Bevacizumab to Irinotecan- and Oxaliplatin-Based Preoperative Chemotherapy Regimens Does Not Increase Morbidity after Resection of Colorectal Liver Metastases

Srinevas K. Reddy, Michael A. Morse, Herbert I. Hurwitz, Johanna C. Bendell, Tong J. Gan, Steven E. Hill, Bryan M. Clary

Research output: Contribution to journalArticlepeer-review

163 Scopus citations

Fingerprint Dive into the research topics of 'Addition of Bevacizumab to Irinotecan- and Oxaliplatin-Based Preoperative Chemotherapy Regimens Does Not Increase Morbidity after Resection of Colorectal Liver Metastases'. Together they form a unique fingerprint.

Medicine & Life Sciences